NextCure (NXTC) Long-Term Debt Issuances (2018 - 2021)
NextCure (NXTC) posted quarterly Long-Term Debt Issuances of $417000.0 for Q2 2021, little changed year-over-year from $417000.0 in Q2 2020, and little changed quarter-over-quarter from $417000.0 in Q1 2021.
NextCure (NXTC) Long-Term Debt Issuances (2018 - 2021) Analysis & Trends
NextCure's Long-Term Debt Issuances history runs 4 years deep, the most recent figure standing at $417000.0 for Q2 2021.
- In Q2 2021, Long-Term Debt Issuances changed 0.0% year-over-year to $417000.0; the TTM figure through Dec 2021 stood at $1.2 million (down 18.14% YoY), while the FY2021 annual figure was $3.5 million, up 127.44% from the prior year.
- Long-Term Debt Issuances for Q2 2021 stood at $417000.0, roughly flat from $417000.0 in the prior quarter.
- The five-year high for Long-Term Debt Issuances was $4.4 million in Q2 2019, with the low at $100000.0 in Q1 2018.
- The 4-year median for Long-Term Debt Issuances is $346500.0 (2020), against an average of $608416.7.
- The sharpest annual moves came in 2019 and 2020: Long-Term Debt Issuances soared 4331.0% in 2019, then tumbled 90.59% in 2020.
- NextCure's Long-Term Debt Issuances stood at $100000.0 in 2018, then jumped by 4331.0% to $4.4 million in 2019, then tumbled by 90.61% to $416000.0 in 2020, then advanced by 0.24% to $417000.0 in 2021.
- Business Quant data shows NXTC's Long-Term Debt Issuances at $417000.0 in Q2 2021, $417000.0 in Q1 2021, and $416000.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | NextCure | 33.72 Mn | 33.72 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 417,000.00 |
| Jun 30, 2021 | 417,000.00 |
| Mar 31, 2021 | 417,000.00 |
| Mar 31, 2021 | 417,000.00 |
| Dec 31, 2020 | 416,000.00 |
| Dec 31, 2020 | 416,000.00 |
| Sep 30, 2020 | 417,000.00 |
| Sep 30, 2020 | 417,000.00 |
| Jun 30, 2020 | 417,000.00 |
| Jun 30, 2020 | 417,000.00 |
| Mar 31, 2020 | 277,000.00 |
| Mar 31, 2020 | 277,000.00 |
| Jun 30, 2019 | 4.43 Mn |
| Jun 30, 2019 | 4.43 Mn |
| Mar 31, 2019 | 109,000.00 |
| Mar 31, 2019 | 109,000.00 |
| Dec 31, 2018 | 100,000.00 |
| Dec 31, 2018 | 100,000.00 |
| Sep 30, 2018 | 100,000.00 |
| Sep 30, 2018 | 100,000.00 |